SMS Pharmaceuticals Limited (NSE: SMSPHARMA; BSE: 532815) has received the European Directorate for the Quality of Medicines & HealthCare (EDQM) certification to supply Ibuprofen from its Visakhapatnam (Vizianagaram) manufacturing facility. This certification follows a successful inspection conducted from February 28 to March 1, 2024, and confirms the facility’s compliance with the EU’s Good Manufacturing Practices (GMP).
The certification is a significant achievement for SMS Pharma as it allows the company to export its Ibuprofen Active Pharmaceutical Ingredients (API) to the European market, further strengthening its global presence. Mr. P. Vamsi Krishna, Executive Director, stated, “This certification reaffirms our commitment to quality and compliance with global standards, positioning us as a trusted partner in the pharmaceutical industry.”
SMS Pharmaceuticals is a leading manufacturer of APIs and intermediates, serving clients in over 70 countries with two state-of-the-art manufacturing facilities in Hyderabad and Vizianagaram.
